Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Bruce A. Mungall, Bernard Hoet, Javier Nieto Guevara & Lamine Soumahoro. (2022) A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Review of Vaccines 21:2, pages 201-214.
Read now
Read now
Christophe Sauboin, Jovan Mihajlović, Maarten Jacobus Postma, Regine Geets, Djurdja Antic & Baudouin Standaert. (2021) Informing decision makers seeking to improve vaccination programs: case-study Serbia. Journal of Market Access & Health Policy 9:1.
Read now
Read now
Javier Nieto Guevara, Dorota Borys, Rodrigo DeAntonio, Adriana Guzman-Holst & Bernard Hoet. (2020) Interchangeability between pneumococcal conjugate vaccines for pediatric use: a systematic literature review. Expert Review of Vaccines 19:11, pages 1011-1022.
Read now
Read now
Nicolas Lecrenier, Alen Marijam, Jan Olbrecht, Lamine Soumahoro, Javier Nieto Guevara & Bruce Mungall. (2020) Ten years of experience with the pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (Synflorix) in children. Expert Review of Vaccines 19:3, pages 247-265.
Read now
Read now
Carolina López-Sanguos, Irene Rivero Calle, Carmen Rodriguez Tenreiro, Peter Francis Raguindin & Federico Martinón-Torres. (2019) Safety and immunogenicity of pneumococcal conjugate vaccines in preterm infants. Expert Opinion on Drug Safety 18:4, pages 253-259.
Read now
Read now
Articles from other publishers (12)
Andreas Palmborg, Mette Skovdal, Tor Molden, Heidi Åhman, Lingjing Chen & Jonas Banefelt. (2023) Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination—A longitudinal study over 10 years based on public surveillance data in the Nordics. PLOS ONE 18:6, pages e0287378.
Crossref
Crossref
Anand Kawade, Girish Dayma, Aditi Apte, Nilima Telang, Meenakshi Satpute, Emma Pearce, Lucy Roalfe, Rakesh Patil, Yanyun Wang, Navideh Noori, Arun Gondhali, Sanjay Juvekar, Assaf P. Oron, Sonali Sanghavi, David Goldblatt, Ron Dagan & Ashish Bavdekar. (2023) Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children. Vaccine 41:19, pages 3066-3079.
Crossref
Crossref
Aleksandra Polkowska, Hanna Rinta-Kokko, Maija Toropainen, Arto A. Palmu & J. Pekka Nuorti. (2021) Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland. Vaccine 39:23, pages 3216-3224.
Crossref
Crossref
Nicola Principi & Susanna Esposito. (2021) Pneumococcal Disease Prevention: Are We on the Right Track?. Vaccines 9:4, pages 305.
Crossref
Crossref
Auliya A. Suwantika, Neily Zakiyah, Arif S. W. Kusuma, Rizky Abdulah & Maarten J. Postma. (2020) Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia. Vaccines 8:2, pages 233.
Crossref
Crossref
Malihe Masomian, Zuleeza Ahmad, Lai Ti Gew & Chit Laa Poh. (2020) Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection. Vaccines 8:1, pages 132.
Crossref
Crossref
Regie Lyn P. Santos-Cortez, Mahmood F. Bhutta, Joshua P. Earl, Lena Hafrén, Michael Jennings, Joshua C. Mell, Michael E. Pichichero, Allen F. Ryan, Hilda Tateossian & Garth D. Ehrlich. (2020) Panel 3: Genomics, precision medicine and targeted therapies. International Journal of Pediatric Otorhinolaryngology 130, pages 109835.
Crossref
Crossref
Caroline Colijn, Jukka Corander & Nicholas J. Croucher. (2020) Designing ecologically optimized pneumococcal vaccines using population genomics. Nature Microbiology 5:3, pages 473-485.
Crossref
Crossref
Bianchini, Argentiero, Camilloni, Silvestri, Alunno & Esposito. (2019) Vaccination against Paediatric Respiratory Pathogens. Vaccines 7:4, pages 168.
Crossref
Crossref
Marco Aurelio P. Safadi, Federico Martinon-Torres, Lily Yin Weckx, Edson Duarte MoreiraJuniorJunior, Eduardo Jorge da Fonseca Lima, Arnold Willemsen, Daniela Toneatto, Md Ahsan Habib & Dorota Borys. (2019) Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial. Vaccine 37:35, pages 4858-4863.
Crossref
Crossref
Susanna Esposito & Nicola Principi. (2019) Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?. Future Microbiology 14:11, pages 921-923.
Crossref
Crossref
Shabir A Madhi & David Goldblatt. (2019) The duopoly of ten-valent and 13-valent pneumococcal conjugate vaccines: do they differ?. The Lancet Infectious Diseases 19:5, pages 453-454.
Crossref
Crossref